News
Latest NewsReproUnion Innovation Workshop: Transforming research into life-changing solutions
The ReproUnion Innovation Platform facilitated its first workshop to explore how cutting-edge research can be transformed into impactful, market-ready solutions. Innovation experts stories of successful research entrepreneurs and explained how to navigate differences in intellectual property (IP) rights in cross-border projects.
SEK 4.2 million grant to explore the impact of daily exposure to hormone-disrupting chemicals on fertility outcomes
The funding from the Swedish Research Council will enable the research team to use the ReproUnion Biobank and Infertility Cohort (RUBIC) to analyze data from more than 500 couples across Denmark and Sweden, including a broad panel of hormone-disrupting chemicals, vitamins, and other biomarkers.
MVA Summit features RUBIC: The golden egg in women’s and men’s fertility research
At the Medicon Valley Alliance Summit ReproUnion presented how research using the cross-border biobank can bring us closer to understand the reasons for infertility, while underlining the importance of the couple-centric approach, which makes RUBIC a true pioneer in this field.
ReproUnion gains media attention in both Finland and Sweden
During the autumn Helsingin Sanomat visited Medicon Valley and published an in-depth article about the building of bridges in science and how the Öresund Region is setting a global example in reproductive health innovation. A couple of weeks later Altinget.se featured an opinion piece in connection with Father’s Day in Sweden, which called for new ways of supporting infertile couples.
Welcome back Mette Bach Dyremose
We’re thrilled to welcome back Mette Bach Dyremose to the ReproUnion Management Team as she takes on a part-time role to lead ReproUnion's communication efforts! With over 20 years of experience in...
RUBIC Seminar – The Team Makes the Dream Work
On October 3. we gathered more than 60 people for the 2024 RUBIC Seminar, a networking event for the dedicated people involved in patient recruitment, clinical visits, sample preparation, and data...
Defective sperm doubles the risk of preeclampsia
We’re excited to share new findings from Lund University, led by ReproUnion researcher Aleksander Giwercman. For the first time, researchers have linked specific sperm defects to pregnancy...
Tour de Health
Great to have ReproUnion on the agenda on this years Tour de Health conference hosted by Ferring Pharmaceuticals arranged by Healthcare Denmark. Lars Løkke Rasmussen attended the conference and his...
We wellcome Katalin Vikuk, Innovation Manager for ReproUnion
We are excited to introduce Katalin Vikuk, Innovation Manager for the ReproUnion project. Katalin started in the position on the 1st of July. With a comprehensive background in mental health and...
Big News from ReproUnion!
We're thrilled to announce that Professor, founder and CEO Yvonne Lundberg Giwercman a dedicated ReproUnion researcher, was selected to present her start-up Dx4Life at the Nordic Life Science Days!...